Stevens-Johnson Syndrome (SJS) is a serious skin condition that causes the outer layers of skin (epidermis) to separate from the inner skin layers (dermis). Affecting approximately 30% of the epidermis, SJS is considered a milder form of Toxic Epidermal Necrolysis Syndrome (TENS), which can cause separation in 100% of the outer layers of skin.
While this hypersensitivity in the skin may arise from a variety of unknown causes, over the years SJS cases have been connected to the use of sulfur-based drugs, such as anti-seizure medications Dilantin and Tegretol, as well as the anti-inflammatory drug Sulindac and the antibiotic Levaquin, which is commonly used to treat bacterial infections ranging from pneumonia to urinary tract infections. SJS has even been linked to drugs as common as Motrin, Ibuprofen and Advil.
Typical SJS symptoms may include:
- blisters on the mucous membranes
- body aches
- flat red rash
- small patches of peeling skin
Drug manufacturers and the FDA have a responsibility to warn about and investigate the associations between medications and the onset of SJS. Every case is a chance to hold these corporate giants and governing bodies accountable for the health and safety of American citizens.
We understand that each SJS case comes with its own history and possible causes, but anyone affected by this potentially fatal skin condition deserves a chance for legitimate compensation. Depending on the circumstances, Douglas & London may be able to help you or someone you know who has suffered from SJS sue a drug manufacturer for negligence, product liability or deceit/concealment. Call us today to learn more about ongoing SJS litigation.